About
Experts
Webinars & Conferences
Antimicrobial Viewpoints
Resources
- Library
- Antimicrobial Encyclopaedia
JOIN US
My account
- Logout

Loading...

Webinars

You are here:Home-Webinars

Register now for our next webinar:

Assay development for measuring antibiotic accumulation in Gram-negative bacteria — Assay development for measuring antibiotic accumulation in Gram-negative bacteria
19 May 2020

Probability of target attainment analyses for dose selection in antimicrobial drug development — Probability of target attainment analyses for dose selection in antimicrobial drug development
12 May 2020

Inhaled antimicrobials: Do we get the drug to the bug? — Inhaled antimicrobials: Do we get the drug to the bug?
28 April 2020

PK/PD murine infection models: Focus on study elements, variability, and interpretation of results — PK/PD murine infection models: Focus on study elements, variability, and interpretation of results
27 February 2020

Non-traditional antibacterial therapeutic options and challenges — Non-traditional antibacterial therapeutic options and challenges
4 February 2020

Testing for the potential of emergence of antimicrobial resistance — Testing for the potential of emergence of antimicrobial resistance
21 January 2020

Innovation in point-of-care diagnostics for sepsis and bloodstream infections — Innovation in point-of-care diagnostics for sepsis and bloodstream infections
26 November 2019

Converting Gram-positive-only compounds into broad-spectrum antibiotics — Converting Gram-positive-only compounds into broad-spectrum antibiotics
7 November 2019

Natural product antibiotics: from traditional screening to novel discovery approaches — Natural product antibiotics: from traditional screening to novel discovery approaches
3 October 2019

Models for antimicrobial R&D: Advanced and complex in vivo models for infectious disease research — Models for antimicrobial R&D: Advanced and complex in vivo models for infectious disease research
10 September 2019

Models for antimicrobial R&D: <br>Computational modelling for population PK and PKPD</br> — Models for antimicrobial R&D: Computational modelling for population PK and PKPD
20 August 2019

Enabling academia to fill the discovery gap – Learnings from industry and funders — Enabling academia to fill the discovery gap – Learnings from industry and funders
18 July 2019

« Previous
1
2
3
Next »

Share

Facebook Twitter LinkedIn Reddit Email

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

Content

Antimicrobial Viewpoints (32)
Conferences (17)
Experts (100)
External webinars (19)
Uncategorized (2)
Webinars (35)

Search site

Search for:

CONNECT

Twitter
LinkedIn
YouTube

GARDP
DNDi

© All Rights Reserved

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy